AZNCF
Price
$170.00
Change
-$2.30 (-1.33%)
Updated
Oct 7 closing price
Capitalization
267.14B
SNY
Price
$48.79
Change
-$0.40 (-0.81%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
121.05B
16 days until earnings call
Interact to see
Advertisement

AZNCF vs SNY

Header iconAZNCF vs SNY Comparison
Open Charts AZNCF vs SNYBanner chart's image
AstraZeneca
Price$170.00
Change-$2.30 (-1.33%)
Volume$1.9K
Capitalization267.14B
Sanofi ADS
Price$48.79
Change-$0.40 (-0.81%)
Volume$56.25K
Capitalization121.05B
AZNCF vs SNY Comparison Chart in %
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZNCF vs. SNY commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNCF is a Buy and SNY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (AZNCF: $172.10 vs. SNY: $48.80)
Brand notoriety: AZNCF and SNY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZNCF: 5% vs. SNY: 118%
Market capitalization -- AZNCF: $267.14B vs. SNY: $121.05B
AZNCF [@Pharmaceuticals: Major] is valued at $267.14B. SNY’s [@Pharmaceuticals: Major] market capitalization is $121.05B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $758.15B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $96.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZNCF’s FA Score shows that 1 FA rating(s) are green whileSNY’s FA Score has 1 green FA rating(s).

  • AZNCF’s FA Score: 1 green, 4 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, AZNCF is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZNCF’s TA Score shows that 6 TA indicator(s) are bullish while SNY’s TA Score has 4 bullish TA indicator(s).

  • AZNCF’s TA Score: 6 bullish, 4 bearish.
  • SNY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AZNCF is a better buy in the short-term than SNY.

Price Growth

AZNCF (@Pharmaceuticals: Major) experienced а +5.87% price change this week, while SNY (@Pharmaceuticals: Major) price change was -1.93% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.75%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +23.81%.

Reported Earning Dates

SNY is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.75% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZNCF($267B) has a higher market cap than SNY($121B). AZNCF has higher P/E ratio than SNY: AZNCF (32.41) vs SNY (16.32). AZNCF YTD gains are higher at: 32.385 vs. SNY (5.666). AZNCF has higher annual earnings (EBITDA): 16.8B vs. SNY (12.6B). SNY has more cash in the bank: 15.4B vs. AZNCF (7.11B). SNY has less debt than AZNCF: SNY (22.3B) vs AZNCF (32.8B). AZNCF has higher revenues than SNY: AZNCF (56.5B) vs SNY (45.7B).
AZNCFSNYAZNCF / SNY
Capitalization267B121B221%
EBITDA16.8B12.6B133%
Gain YTD32.3855.666572%
P/E Ratio32.4116.32199%
Revenue56.5B45.7B124%
Total Cash7.11B15.4B46%
Total Debt32.8B22.3B147%
FUNDAMENTALS RATINGS
AZNCF vs SNY: Fundamental Ratings
AZNCF
SNY
OUTLOOK RATING
1..100
3120
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
3768
SMR RATING
1..100
4661
PRICE GROWTH RATING
1..100
4554
P/E GROWTH RATING
1..100
5991
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (4) in the Pharmaceuticals Major industry is in the same range as AZNCF (23) in the null industry. This means that SNY’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's Profit vs Risk Rating (37) in the null industry is in the same range as SNY (68) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to SNY’s over the last 12 months.

AZNCF's SMR Rating (46) in the null industry is in the same range as SNY (61) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to SNY’s over the last 12 months.

AZNCF's Price Growth Rating (45) in the null industry is in the same range as SNY (54) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to SNY’s over the last 12 months.

AZNCF's P/E Growth Rating (59) in the null industry is in the same range as SNY (91) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to SNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNCFSNY
RSI
ODDS (%)
Bearish Trend 2 days ago
25%
Bearish Trend 2 days ago
48%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
40%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 6 days ago
51%
Declines
ODDS (%)
Bearish Trend 10 days ago
49%
Bearish Trend 2 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
45%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TSMU46.713.00
+6.86%
GraniteShares 2x Long TSM Daily ETF
FRNW20.630.21
+1.03%
Fidelity Clean Energy ETF
IWS140.500.63
+0.45%
iShares Russell Mid-Cap Value ETF
PAXS16.520.06
+0.36%
PIMCO Access Income Fund
BSJU26.07-0.07
-0.29%
Invesco BulletShares 2030 HY Corp Bd ETF

AZNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZNCF has been loosely correlated with AZN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AZNCF jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZNCF
1D Price
Change %
AZNCF100%
+1.24%
AZN - AZNCF
48%
Loosely correlated
-0.57%
NVS - AZNCF
24%
Poorly correlated
+0.58%
SNY - AZNCF
23%
Poorly correlated
-0.80%
MRK - AZNCF
19%
Poorly correlated
-1.38%
BAYRY - AZNCF
18%
Poorly correlated
-1.77%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
-0.80%
SNYNF - SNY
61%
Loosely correlated
-5.25%
GSK - SNY
53%
Loosely correlated
-0.34%
NVS - SNY
53%
Loosely correlated
+0.58%
PFE - SNY
53%
Loosely correlated
-2.25%
AZN - SNY
53%
Loosely correlated
-0.57%
More